Abstract
Male Fischer rats received either methadone (a long-acting opioid agonist, 10 mg/kg/day) or saline (24 microliters/day) subcutaneously by osmotic minipumps for 7 days. Chronic steady-state methadone administration did not alter (a) corticotropin-releasing factor (CRF) mRNA in the hypothalamus, (b) proopiomelanocortin (POMC) and CRF type 1 receptor (CRF-R1) mRNAs in the anterior lobe and neurointermediate/posterior lobe of the pituitary, or (c) circulating levels of corticosterone. No change was found in levels of either POMC mRNA in the hypothalamus and amygdala, or CRF mRNA in the frontal cortex, olfactory bulb and amygdala. These results demonstrate that neither the activity of the hypothalamic-pituitary-adrenal axis, nor the beta-endorphin and CRF systems in the brain, are altered by steady-state occupancy of opioid receptors with the long-acting opioid agonist methadone.
References
Jun 11, 1990·Brain Research·D M BronsteinH Akil
Dec 30, 1986·Regulatory Peptides·P M Plotsky
Sep 1, 1988·The Journal of Physiology·S L Lightman, W S Young
Feb 5, 1973·JAMA : the Journal of the American Medical Association·M J Kreek
Dec 1, 1984·Neuropeptides·M J KreekN Hartman
Mar 14, 1983·Life Sciences·S W LambertsE Del Pozo
Oct 1, 1983·Neuroendocrinology·V V RagavanA G Frantz
Jan 1, 1983·Life Sciences·M J KreekA G Frantz
May 1, 1984·Neuroendocrinology·J C Buckingham, T A Cooper
Jul 1, 1981·Drug and Alcohol Dependence·B S ZiringL T Brown
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·E PotterW Vale
Jan 1, 1995·Journal of Addictive Diseases·L BorgM J Kreek
Jan 1, 1996·Peptides·Y ZhouM J Kreek
Citations
Jan 20, 2012·Psychopharmacology·Erin CumminsFrancesco Leri
Nov 17, 2009·Brain Research·Yan ZhouMary Jeanne Kreek
Jan 3, 2001·European Journal of Pharmacology·D LichtermannM L Rao
Jun 21, 2002·Neuroscience·G P McNally, H Akil
Aug 26, 1998·Drug and Alcohol Dependence·M J Kreek, G F Koob
Dec 3, 2008·Behavioral Neuroscience·N DevidzeM J Kreek
Sep 5, 2002·Nature Reviews. Drug Discovery·Mary Jeanne KreekEduardo Butelman
Oct 21, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Francesco LeriMary Jeanne Kreek
Oct 2, 2012·The Journal of Clinical Investigation·Mary Jeanne KreekEduardo R Butelman
Jul 31, 2013·Peptides·Ying NieTheodore C Friedman
Oct 12, 2010·Medical Hypotheses·Albert Stuart Reece
May 1, 2009·Expert Opinion on Drug Discovery·Erin Cummins, Francesco Leri
Mar 25, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Francesco LeriJane Stewart
Jan 5, 2000·Journal of Neurochemistry·P A IredaleR S Duman
Sep 5, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Francesco LeriJane Stewart
Aug 14, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Hani HoushyarMary F Dallman
Apr 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·James H SchlugerMary Jeanne Kreek
Sep 7, 2004·The Journal of Pharmacology and Experimental Therapeutics·Jan K MelicharDavid J Nutt
Oct 6, 1997·Science·G F Koob, M Le Moal
Jul 27, 2000·Annals of the New York Academy of Sciences·M J Kreek
Dec 7, 2017·Journal of Psychopharmacology·Stephen DanielsFrancesco Leri
Oct 7, 2004·Neuropharmacology·Mary Jeanne KreekEduardo R Butelman